Insider Transactions in Q3 2022 at Dyne Therapeutics, Inc. (DYN)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2022
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
840
-3.19%
|
$10,920
$13.7 P/Share
|
|
Sep 20
2022
|
Jonathan Mc Neill Chief Business Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,246
-2.1%
|
$16,198
$13.7 P/Share
|
|
Sep 20
2022
|
Susanna Gatti High Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,629
-3.68%
|
$34,177
$13.7 P/Share
|
|
Sep 20
2022
|
Joshua T Brumm CEO & President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,836
-5.47%
|
$153,868
$13.7 P/Share
|
|
Sep 20
2022
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,413
-2.7%
|
$18,369
$13.7 P/Share
|
|
Sep 15
2022
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
712
-1.34%
|
$9,968
$14.05 P/Share
|
|
Sep 15
2022
|
Joshua T Brumm CEO & President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,480
-1.58%
|
$48,720
$14.05 P/Share
|
|
Sep 15
2022
|
Susanna Gatti High Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
786
-1.09%
|
$11,004
$14.05 P/Share
|
|
Sep 15
2022
|
Jonathan Mc Neill Chief Business Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
494
-0.82%
|
$6,916
$14.05 P/Share
|
|
Sep 15
2022
|
Wildon Farwell Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
658
-1.01%
|
$9,212
$14.05 P/Share
|
|
Sep 15
2022
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
326
-1.22%
|
$4,564
$14.05 P/Share
|
|
Jul 06
2022
|
Joshua T Brumm CEO & President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,963
-4.75%
|
$87,704
$8.24 P/Share
|
|
Jul 05
2022
|
Joshua T Brumm CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
24,118
+9.46%
|
-
|